MARA Holdings
MARA
MicroStrategy
MSTR
Coinbase
COIN
Tesla
TSLA
Amazon
AMZN
US Stock MarketDetailed Quotes
HALO Halozyme Therapeutics
- 54.800
- -0.570-1.03%
Close Jan 17 16:00 ET
- 54.600
- -0.200-0.36%
Post 20:01 ET
6.97BMarket Cap18.15P/E (TTM)
55.730High54.765Low942.15KVolume55.660Open55.370Pre Close51.93MTurnover0.75%Turnover Ratio26.10P/E (Static)127.23MShares65.53352wk High15.40P/B6.90BFloat Cap33.15052wk Low--Dividend TTM125.92MShs Float65.533Historical High--Div YieldTTM1.74%Amplitude1.410Historical Low55.115Avg Price1Lot Size
About Halozyme Therapeutics Company
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.
Company Profile
SymbolHALO
Company NameHalozyme Therapeutics
Listing DateNov 1, 2004
Founded1998
CEODr. Helen I. Torley, M.R.C.P.,MB.Ch.B.
MarketNASDAQ
Employees373
Fiscal Year Ends12-31
Address12390 El Camino Real
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-858-794-8889
Websitehttp://www.halozyme.com
Company Executives
- Name
- Position
- Salary
- Dr. Helen I. Torley, M.R.C.P.,MB.Ch.B.
- Director, President and Chief Executive Officer
- 11.82M
- Mark Snyder
- Senior Vice President, Chief Legal Officer, General Counsel, Chief Compliance Officer and Corporate Secretary
- 3.61M
- Nicole LaBrosse
- Senior Vice President, Chief Financial Officer and Principal Accounting Officer
- 3.85M
- Dr. Michael J. LaBarre
- Senior Vice President and Chief Technical Officer
- 3.24M
- Jeffrey W. Henderson
- Chairman of the Board
- 555.02K
- Barbara G. Duncan
- Independent Director
- 528.15K
- Connie L. Matsui
- Independent Director
- 460.02K
- Dr. Mahesh Krishnan, M.B.A.
- Independent Director
- --
- Matthew L. Posard
- Independent Director
- 471.83K
- Bernadette M. Connaughton
- Independent Director
- 470.02K
- Moni Miyashita
- Independent Director
- 455.02K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.